LRRK2-IN-17

Overview

LRRK2-IN-17 (Compound 6) is an orally active LRRK2 inhibitor ( IC 50 : 3.5 and 3.3 nM for WT and G2019S, respectively). LRRK2-IN-17 inhibits RET kinase ( IC 50 : 59 nM). LRRK2-IN-17 can be used in cancer and Parkinson's disease (PD) research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > LRRK2 | Products > Signaling Pathways > RET

Product Information

• Catalog No.: HY-172952
• CAS No.: 2101821-86-5
• Molecular Formula: C18H18N8
• Molecular Weight: 346.39
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source